期刊文献+

奥扎格雷钠治疗缺血性脑血管病98例的临床疗效

Clinical effect of ozagrel sodium in the treatment of ischemic cerebrovascular disease in 98 cases
下载PDF
导出
摘要 目的:探讨奥扎格雷钠治疗缺血性脑血管病的效果。方法:收治缺血性脑血管病患者196例,随机分为对照组和治疗组各98例,对照组采用维脑路通治疗,治疗组采用奥扎格雷钠治疗,比较两组治疗效果。结果:治疗组总有效率92.86%,明显高于对照组的78.57%(P<0.01)。结论:奥扎格雷钠治疗缺血性脑血管病疗效显著。 Objective:To explore the effect of ozagrel sodium in the treatment of ischemic cerebrovascular disease.Methods:196patients with ischemic cerebrovascular disease were selected.They were randomly divided into the control group and the treatmentgroup with 98 cases in each.The control group was treated with venoruton,and the treatment group was treated with ozagrel sodium.We compared the therapeutic effect of two groups.Results:In the treatment group,the total effective rate of 92.86% wassignificantly higher than 78.57% of the control group(P<0.01).Conclusion:The effect of ozagrel sodium in the treatment ofischemic cerebrovascular disease was significant.
作者 屈海 张学林 Qu Hai;Zhang Xuelin(Linyi Health School of Shandong 276000;The Traditional Chinese Medicine Hospital of Tianqiao,Shenyang,Liaoning 110000)
出处 《中国社区医师》 2016年第19期28-29,共2页 Chinese Community Doctors
关键词 奥扎格雷钠 缺血性脑血管病 治疗 Ozagrel sodium Ischemic cerebrovascular disease Treatment
  • 相关文献

参考文献3

二级参考文献30

  • 1贺茂林.应重视急性缺血性卒中动静脉联合溶栓治疗的研究[J].中国脑血管病杂志,2004,1(8):337-338. 被引量:17
  • 2贺茂林,陈清棠.急性脑梗死溶栓治疗的血管再通率[J].中华老年心脑血管病杂志,1999,1(1):57-60. 被引量:36
  • 3[1]NINDS t-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med, 1995, 333: 1581-1587.
  • 4[2]Marler J, Tilley BC, Mci L, et al. Earlier treatment associated with better outcome in the NINDS t-PA trial. Stroke, 1999, 30: 244.
  • 5[3]NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA Stroke Trial.Stroke, 1997, 28: 2119-2125.
  • 6[4]NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke, 1997, 28:2109-2118.
  • 7[5]Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial rt-PA versus intra-arterial therapy of acute ischemic stroke: emergency management of stroke (EMS) bridging trial. Stroke, 1999, 30: 2598-2605.
  • 8[6]Wolpert S, Bruckmann H, Greenlee R, et al. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. Am J Neuro Radiol, 1993, 14: 3-13.
  • 9[8]Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol , 1992, 32: 78-86.
  • 10[10]Furlan A, Higashida R, Weschler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the proact Ⅱ study: a randomized controlled trial. JAMA, 1999, 282: 2003-2011.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部